The UltraMind Solution (141 page)

58
. Ahlbom, A. 2001. Neurodegenerative diseases, suicide and depressive symptoms in relation to EMF.
Bioelectromagnetics
Suppl 5:S132–43.

Chapter 6: Key #1: Optimize Nutrition

1
. Freeman, M. P., et al. 2006. Omega-3 fatty acids: evidence basis for treatment and future research in psychiatry.
J Clin Psychiatry
67 (12):1954–1967. Review.

2
. Hibbeln, J. R., L. R. Nieminen and W. E. Lands. 2004. Increasing homicide rates and linoleic acid consumption among five Western countries, 1961–2000.
Lipids
39 (12):1207–1213.

3
. Gesch, C. B., et al. 2002. Influence of supplementary vitamins, minerals and essential fatty acids on the antisocial behaviour of young adult prisoners: Randomised, placebo-controlled trial.
Br J Psychiatry
181:22–28.

4
. Freeman, M. P. 2006. Omega-3 fatty acids and perinatal depression: a review of the literature and recommendations for future research.
Prostaglandins Leukot Essent Fatty Acids
75 (4–5):291–97.

5
. Richardson, A. I. 2004. Long-chain polyunsaturated fatty acids in childhood developmental and psychiatric disorders.
Lipids
39 (12):1215–1222. Review.

6
. Megson, M. N. 2000. Is autism a G-alpha protein defect reversible with natural vitamin A?
Med Hypotheses
54 (6):979–83.

7
. Parker, G., et al. 2006. Omega-3 fatty acids and mood disorders.
Am J Psychiatry
(2006) 163 (6):969–78. Review. Erratum in
Am J Psychiatry
163 (10):1842.

8
. Crook, T. H., et al. 1997. Effects of phosphatidylserine in age-associated memory impairment.
Neurology
41 (5):644–49.

9
. Hellhammer, J., et al. 2004. Effects of soy lecithin phosphatidic acid and phosphatidylserine complex (PAS) on the endocrine and psychological responses to mental stress.
Stress
7 (2):119–26.

10
. Kidd, P. M. 1999. A review of nutrients and botanicals in the integrative management of cognitive dysfunction.
Altern Med Rev
4 (3):144–61. Review.

11
. Shaw, P., et al. 2007. Polymorphisms of the dopamine D4 receptor, clinical outcome, and cortical structure in attention-deficit/hyperactivity disorder.
Arch Gen Psychiatry
64 (8):921–31.

12
. Nyman, E. S., et al. 2007. ADHD candidate gene study in a population-based birth cohort: Association with DBH and DRD2.
J Am Acad Child Adolesc Psychiatry
46 (12):1614–1621.

13
. Sharma, A., et al. 1999. D4 dopamine receptor-mediated phospholipid methylation and its implications for mental illnesses such as schizophrenia.
Mol Psychiatry
4 (3):235–46.

14
. Das, U. N. 2008. Folic acid and polyunsaturated fatty acids improve cognitive function and prevent depression, dementia, and Alzheimer’s disease. But how and why.
Prostaglandins Leukot Essent Fatty Acids
78 (1):11–19.

15
. Deijen, J. B. et al. 1999. Tyrosine improves cognitive performance and reduces blood pressure in cadets after one week of a combat training course.
Brain Res Bull
48 (2):203–9.

16
. Delgado, P. L., et al. 1990. Serotonin function and the mechanism of antidepressant action. Reversal of antidepressant-induced remission by rapid depletion of plasma tryptophan.
Arch Gen Psychiatry
47 (5):411–18.

17
. Coppen, A., and C. Bolander-Gouaille. 2005. Treatment of depression: time to consider folic acid and vitamin B
₁₂
.
J Psychopharmacol
19 (1):59–65. Review.

18
. Roberts, S. H., et al. 2007. IT. Folate Augmentation of Treatment—Evaluation for Depression (FolATED); Protocol of a randomised controlled trial.
BMC Psychiatry
7 (1):65.

19
. Tiihonen, J., et al. 2006. Antidepressants and the risk of suicide, attempted suicide, and overall mortality in a nationwide cohort.
Arch Gen Psychiatry
63 (12):1358–1367.

20
. Abdou, A. M., et al. 2006. Relaxation and immunity enhancement effects of gamma-aminobutyric acid (GABA) administration in humans.
Biofactors
26 (3):201–8.

21
. El Idrissi, A., et al. 2003. Prevention of epileptic seizures by taurine.
Adv Exp Med Biol
526:515–25.

22
. Courtney, C., et al. 2004. AD2000 Collaborative Group. Long-term donepezil treatment in 565 patients with Alzheimer’s disease (AD2000): randomised double-blind trial.
Lancet
363 (9427):2105–2115.

23
. Hampl, J. S., C.A. Taylor, and C. S. Johnston. 2004. Vitamin C deficiency and depletion in the United States: the Third National Health and Nutrition Examination Survey, 1988 to 1994.
Am J Public Health
94 (5):870–75.

24
. Noble, J. M., A. Mandel, and M. C. Patterson. 2007. Scurvy and rickets masked by chronic neurologic illness: revisiting “psychologic malnutrition.”
Pediatrics
119 (3):e783–90.

25
. Ames, B. N. 2004. A role for supplements in optimizing health: the metabolic tune-up.
Arch Biochem Biophys
423 (1):227–34. Review.

26
. Kaplan, B. J. et al. 2007. Vitamins, minerals, and mood.
Psychol Bull
133 (5):747–60.

27
. Seshadri, S., et al. 2002. Plasma homocysteine as a risk factor for dementia and Alzheimer’s disease.
N Engl J Med
346 (7):476–83.

28
. Ames, B. 2002. High-dose vitamin therapy stimulates variant enzymes with decreased coenzyme binding affinity (increased km): relevance to genetic disease and polymorphisms.
Am J Clin Nutr
75:616–58.

29
. Fairfield, K. 2002. Vitamins for chronic disease prevention in adults, scientific review.
JAMA
287:3116–3126.

30
. Vasquez, A. 2004. The clinical importance of vitamin D (cholecalciferol): A paradigm shift with implications for all health care providers, alternative therapies.

31
. Holick, M. 2004. Vitamin D: importance in the prevention of cancers, type 1 diabetes, heart disease and osteoporosis.
Am J Clin Nutr
79:362–71.

32
. Heaney, R. 2003. Long-latency deficiency disease: insights from calcium and vitamin D.
Am J Clin Nutr
78:912–19.

33
. Mischoulon, D., and M. F. Raab. 2007. The role of folate in depression and dementia.
J Clin Psychiatry
68 Suppl 10:28–33. Review.

34
. James, S. J., et al. 2004. Metabolic biomarkers of increased oxidative stress and
impaired methylation capacity in children with autism.
Am J Clin Nutr
80 (6):1611–17.

35
. Triantafyllou, N. I., et al. 2007. Folate and vitamin B
₁₂
levels in levodopa-treated Parkinson’s disease patients: Their relationship to clinical manifestations, mood and cognition.
Parkinsonism Relat Disord
.

36
. Reif, A., B. Pfuhlmann, and K. P. Lesch. 2005. Homocysteinemia as well as methylenetetrahydrofolate reductase polymorphism are associated with affective psychoses.
Prog Neuropsychopharmacol Biol Psychiatry
(7):1162–1168.

37
. Herbert, V. 1962. Experimental nutritional folate deficiency in man.
Trans Assoc Am Physicians
75:307–20.

38
. Tolmunen, T., et al. 2007. Dietary folate and depressive symptoms are associated in middle-aged Finnish men.
J Nutr
133 (10):3233–3236.

39
. Penninx, B. W., et al. 2000. Vitamin B(12) deficiency and depression in physically disabled older women: Epidemiologic evidence from the Women’s Health and Aging Study.
Am J Psychiatry
157 (5):715–21.

40
. Papakostas, G. I., et al. 2004. Serum folate, vitamin B
₁₂
, and homocysteine in major depressive disorder, Part 1: predictors of clinical response in fluoxetine-resistant depression.
J Clin Psychiatry
65 (8):1090–1095.

41
. Alpert, J. E., et al. 2002. Folinic acid (Leucovorin) as an adjunctive treatment for SSRI-refractory depression.
Ann Clin Psychiatry
14 (1):33–38.

42
. Corrada, M. M., C. H. Kawas, and J. Hallfrisch. 2005. Reduced risk of Alzheimer’s disease with high folate intake: the Baltimore Longitudinal Study of Aging.
Alzheimer’s and Dementia
1:11–18.

43
. Clarke, R., et al. 2007. Low vitamin B-12 status and risk of cognitive decline in older adults.
Am J Clin Nutr
. 86 (5):1384–1391.

44
. Waly, M., et al. 2004. Activation of methionine synthase by insulinlike growth factor-1 and dopamine: a target for neurodevelopmental toxins and thimerosal.
Mol Psychiatry
9 (4):358–70.

45
. Gerrior, S., and L. Bente. 2007. “Nutrient Content of the U.S. Food Supply, 1909–94.” U.S. Department of Agriculture, Center for Nutrition Policy and Promotion. Home Economics Report No. 53.

46
. Alpaslan, M., and H. Gunduz. 2000. The effects of growing conditions on oil content, fatty acid composition and tocopherol content of some sunflower varieties produced in Turkey.
Die Nahrung
(Germany): 44 (6):434–37.

47
. Composition of Foods: Raw, Processed, Prepared. USDA National Nutrient Database for Standard Reference, Release 15. U.S. Department of Agriculture, Agricultural Research Service, Beltsville Human Nutrition Research Center, Nutrient Data Laboratory (2002),
www.ars.usda.gov
.

48
. Wilkins, C. H., et al. 2006. Vitamin D deficiency is associated with low mood and worse cognitive performance in older adults.
Am J Geriatr Psychiatry
14 (12):1032–40.

49
. Gloth, F. M. III, W. Alam, and B. Hollis. 1999. Vitamin D vs. broad spectrum phototherapy in the treatment of seasonal affective disorder.
J Nutr Health Aging
3 (1):5–7.

50
. Cannell, J. J. 2008. Autsim and vitamin D.
Med Hypotheses
70 (4):750–59.

51
. Autier, P., and S. Gandini. 2007. Vitamin D supplementation and total mortality: a metaanalysis of randomized controlled trials.
Arch Intern Med
167 (16):1730–1737. Review.

52
. Holick, M. F. 2006. Vitamin D deficiency.
N Engl J Med
357 (3):266–81. Review.

53
. Holick, M. 2004. Sunlight and vitamin D for bone health and prevention of autoimmune
diseases, cancers and cardiovascular disease.
Am J Clin Nutr
(80) suppl: 1678S–1688S.

54
. Tong, G. M., and R. K. Rude. 2005. Magnesium deficiency in critical illness.
J Intensive Care Med
20 (1):3–17. Review.

55
.
www.who.int/publications/cra/chapters/volume1/0257-0280.pdf

56
. Nowak, G., B. Szewczyk, and A. Pilc. 2005. Zinc and depression. An update.
Pharmacol Rep
57 (6):713–18. Review.

57
. Heleniak, E. P., and S.W. Lamola 1986. A new prostaglandin disturbance syndrome in schizophrenia: delta-6-pyroluria.
Med Hypotheses
19 (4):333–38. Review.

58
. Hoffer, A., and M. Mahon. 1961. The presence of unidentified substances in the urine of psychiatric patients.
J Neuropsychiatr
2:331–62.

59
. McGinnis, W. R., et al. 2008. Discerning the Mauve Factor, pending publication Alter Thera Health Med.

60
. Benton, D., and R. Cook. 1990. Selenium supplementation improves mood in a double-blind crossover trial.
Psychopharmacology
(Berl). 102 (4):549–50.

Chapter 7: Key #2: Balance Your Hormones

1
. Cordain, L., et al. 2005. Origins and evolution of the Western diet: Health implications for the 21st century.
Am J Clin Nutr
8 (2):341–54. Review.

2
.
http://www.cspinet.org/new/sugar_limit.html
.

3
. Kinoshita, J.; Alzheimer Research Forum. 2006. Alzheimer Research Forum live discussion: Insulin resistance: a common axis linking Alzheimer’s, depression, and metabolism?
J Alzheimers Dis
9 (1): 89–93.

4
. Yaffe, K., et al. 2004. The metabolic syndrome, inflammation, and risk of cognitive decline.
JAMA
292 (18):2237–2242.

5
.
NY Times
, January 14, 2003.